| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |